We work at the intersection of biotechnology, graphene nanotechnology, digital health and artificial intelligence, building solutions that improve biological safety and are ready for real-world deployment.
Since 2016, INTERMERCATUS Tech has been developing graphene-based technologies and advanced medical solutions. Our focus is the responsible transfer of scientific research into safe, scalable technologies that support healthcare systems, industry and society.
Modern agriculture and animal husbandry face rising biological pressure. Our graphene-based solutions support soil health, crop stability and livestock biosecurity while preserving natural balance.
Protect crops while preserving soil biology, restoring fertility and reducing reliance on chemical treatments.
See moreProtect enclosed growing spaces from fungal pressure without aggressive chemicals.
See moreBiosecurity in poultry houses that eliminates pathogens without harming birds or infrastructure.
See moreSafe, long-lasting pathogen control without chemical residues or infrastructure damage.
See moreA single-layer hexagonal carbon lattice delivers extraordinary strength and antibacterial properties, already transforming wound care, dentistry and veterinary medicine.
Protect wounds from infection and accelerate regeneration for surgical wounds, burns and ulcers.
See moreEnhance implant safety, strengthen fillings and improve oral hygiene with antibacterial protection.
See moreImprove animal hygiene and prevent infection with safer, more sustainable health solutions.
See moreTransport, food, laundries and hospitality need hygiene that doesn't compromise human health or material durability. Our graphene oxide technology offers long-lasting biological protection.
Long-lasting, safe protection for vehicles and infrastructure without corrosion or damage.
See moreFood safety across processing and transport without residues or environmental harm.
See moreLong-lasting, chemical-free hygiene for hotels, restaurants and kitchens.
See moreWe work with business partners through B2B supply, OEM cooperation and joint implementation models, built on transparency, scalability and long-term technological value.
We operate in high-growth sectors driven by global megatrends: biotechnology, advanced materials, digital health, AI and CLEANTECH. A diversified ecosystem enabling scalable, resilient growth.
Laboratory data on our graphene oxide platform: how fast it reduces pathogens, and how long that protection lasts on treated surfaces and textiles.
Pathogen reduction over time
Log-scale reduction of Pseudomonas / E. coli, MRSA, enveloped viruses and Candida / Aspergillus on contact. Up to 99.999% (Log 5) reduction protects processing and slaughter lines, greenhouse environments and large-scale farm biosecurity.
HexyTrix™ textile vs standard control
Degree of pathogen reduction (Log) measured from application through 2H, 4H, 6H and 8H. Textile treated with HexyTrix™ maintains protection where standard fabric loses it, delivering lasting, active biosecurity between wash cycles.
Contact us to discuss technology deployment, OEM cooperation, licensing models or strategic partnerships. We're ready to explore solutions tailored to your industry and market.
INTERMERCATUS Tech develops advanced graphene-based solutions for industrial, agricultural and environmental applications, technologies that make operations safer, more efficient and more sustainable.
The roots of INTERMERCATUS Tech date back to 2016, when the first research into graphene and its broad, practical applications began. From the start, development was oriented toward real-world use, spanning biosecurity, environmental protection, functional materials and advanced industrial solutions.
We focus on the responsible transfer of scientific research into scalable, safe and practical technologies that can be effectively implemented in real operating conditions.
At the core is graphene oxide, applied as stable dispersions for hygiene, environmental and industrial use, supporting surface protection, environmental stability and biological control without reliance on aggressive chemistry.
We're developing a non-invasive gastric pouch system introduced laparoscopically, without traditional gastric suturing, aiming to reduce procedural invasiveness, enhance patient safety, shorten recovery and maintain high treatment effectiveness.
Our medical software records patient conversations, transcribes them automatically and intelligently generates medical documentation. Our AI analyzes clinical data, summarizes multi-year patient histories and supports diagnostic and therapeutic decisions.
INTERMERCATUS Tech is headquartered in the United States and operates across Germany, Poland, the United Kingdom, Africa, Albania and Uzbekistan. The company is part of the family-and-friends investment fund LEMARRC, providing stable capital, strategic direction and long-term development support.
We translate scientific innovation into industrial, environmental and operational value, combining advanced material science with practical application to build a scalable platform for modern industry and sustainable environments.
To develop and implement advanced technologies for safer, more efficient and more sustainable operational environments, moving scientific knowledge out of the lab and into industry, agriculture, logistics and everyday business.
To build an international platform integrating advanced materials, environmental responsibility and industrial innovation into one coherent ecosystem, setting new standards in industrial hygiene while remaining scalable and aligned with regulation.
Support operational performance across multiple sectors.
Lower dependency on aggressive chemical processes.
Enhance durability of infrastructure and systems.
Safety, sustainability and practical impact by design.
Since 2016 the company has moved from early research to validated medical and protective applications. These are the milestones that shaped our scientific, technological and organizational growth.
The idea to apply graphene nanotechnology to disinfection and biological protection took shape, with early research into graphene's antibacterial, antiviral and antifungal properties, aimed from the start at practical use.
Research entered an advanced stage with intensive laboratory testing and first validation processes, confirming the strong potential of graphene nanostructures in protective and medical applications.
A graphene nanoparticle proved highly effective in filtration and protective solutions, applied in surgical masks where its effectiveness and stability were demonstrated under real-use conditions.
A research laboratory was established in Warsaw and the team expanded significantly. A company was founded in the United Kingdom, the innovative bariatric gastric pouch concept was born, and a dedicated expert team was assembled.
INTERMERCATUS BioTech Inc. was established in the US as the holding entity, acquiring shares in INTERMERCATUS Services Limited in London. The Polish group is led by INTERMERCATUS BioTech S.A. in Warsaw under Ryszard Pikula. Six private investors joined in December 2025, with talks opened across the UAE, Morocco and Turkey.
A phase of further development, project scaling and strengthening of international presence.
Experienced managers leading each division, the people who shape the present and future of INTERMERCATUS.
Experience, passion and vision are the true foundation of our work. Each key division is led by an experienced manager driving the growth of our company and our clients.
We combine professionalism with a visionary approach to deliver top-tier solutions on an international scale.
Reach out to discuss technology deployment, OEM cooperation, licensing models or strategic partnerships across industry, medicine and agriculture.
Thank you. We've received your enquiry and will get back to you shortly at the email you provided.
Long-term intensive use of pesticides, herbicides and chemical fertilizers has depleted soils, disrupted their microbiological balance and stripped away their regenerative capacity. Our graphene oxide technology supports soil hygiene while preserving the biology that keeps land fertile.
Chemical agents act non-selectively, eliminating not only pathogens but also the beneficial microorganisms responsible for healthy soil structure and nutrient cycling.
This disrupts biological equilibrium, reduces water retention and raises susceptibility to disease, driving higher input costs, lower efficiency and growing environmental risk.
Nature already has its own defense and regeneration mechanisms. It needs support, not replacement by aggressive chemistry, and that philosophy sits at the core of our solution.
Built on the HexyTrix graphene oxide platform, our preparation reduces the bacteria, viruses and fungi tied to plant disease without chemically sterilizing the soil or leaving harmful residues.
Delivered as a stable aqueous dispersion, it operates through a physicochemical mechanism rather than toxic action, so natural biological processes in the soil stay intact. It also lowers pathogenic pressure over the longer term, reducing the need for repeated chemical treatment.
An approach where technology works in harmony with nature rather than against it, for producers who want to protect their crops today without compromising the long-term potential of their land.
Enclosed spaces, high humidity, limited air circulation and intensive cycles make greenhouses one of the most demanding environments in agriculture, ideal conditions for fungi and molds. Our graphene oxide technology is designed for exactly these conditions.
Under greenhouse conditions fungal disease spreads rapidly, affecting plants, substrates, structures, irrigation systems and working surfaces. A single lapse in disinfection can contaminate the whole growing environment for cycles to come.
Pathogens survive in construction joints, organic residue and irrigation lines, becoming a persistent source of reinfection.
Aggressive chemicals burden the growing environment, disrupt beneficial microflora and drive pathogen resistance. In enclosed spaces, chemical vapors also threaten worker health and can harm plant growth.
The HexyTrix graphene oxide platform reduces fungi, bacteria and viruses while preserving biological balance and limiting harsh chemical inputs. It works through a physicochemical mechanism, cutting reinfection rates and fungal pressure across production cycles.
A clean, stable and biologically safe environment that supports healthy plant development, long-term crop protection aligned with sustainable agriculture.
High stocking density, elevated humidity, bedding and intensive cycles make poultry houses among the most demanding facilities for hygiene and biosecurity, ideal conditions for bacteria, viruses and fungi to develop quickly.
Pathogens develop in bedding, on structural elements, in drinking systems and ventilation, surviving long after a cycle ends and reinfecting subsequent flocks.
Conventional disinfectants can irritate birds' respiratory systems, damage infrastructure and contribute to microbial resistance.
The HexyTrix platform reduces bacteria, viruses and fungi while limiting the need for aggressive chemical agents inside the breeding environment. It is delivered as a stable aqueous dispersion.
Stable sanitary conditions reduce flock health risks and improve animal welfare, which translates directly into better production performance and enhanced biosecurity.
High animal density, elevated humidity, slurry and limited ventilation make pig farms environments of exceptionally high microbiological risk, promoting bacteria, viruses and fungi that lead to respiratory and digestive disease and weakened immunity.
Pathogens spread easily between animals and persist on surfaces, in construction joints and within waste management systems.
Traditional chemical disinfectants used on pig farms are often highly irritating, corrosive and potentially hazardous for both animals and personnel.
The HexyTrix platform enables effective hygiene management while limiting aggressive chemical agents. It reduces microorganisms through a physicochemical mode of action, without harmful residues, helping maintain a stable microclimate inside the facility.
Regular use reduces biological pressure, supports herd health and contributes to safer, more stable breeding conditions aligned with efficient and sustainable production.
Manure, moisture and constant animal contact with flooring create conditions favorable to bacteria and fungi, which can lead to hoof infections, skin disease, mastitis and other issues affecting milk production and herd condition.
Pathogens accumulate on floors, bedding, grates, drinking systems and ventilation, and full removal with traditional chemical agents is often difficult and costly.
Aggressive disinfectants can also harm animal health, milk quality and the durability of barn infrastructure.
The HexyTrix platform reduces bacteria, viruses and fungi while remaining compatible with animal environments. It is applied as a stable aqueous dispersion.
High hygiene standards improve animal welfare and reduce disease risk, contributing directly to higher milk productivity and long-term herd stability.
High humidity, blood and organic residue and intensive use of working areas make slaughterhouses among the most demanding facilities in the food chain, with extremely high risk of bacterial, viral and fungal growth.
Working surfaces, processing lines, tables and knives, conveyors, drainage, cold storage and warehouses are all risk zones. Pathogens spread rapidly and are hard to fully eliminate on porous surfaces in constant contact with biological material.
The challenge is effective disinfection without affecting meat quality or leaving toxic residues.
Chlorine, aldehydes and aggressive detergents provide rapid antimicrobial action, but long-term use corrodes infrastructure, accelerates wear of processing lines and creates health risks for employees. Tightening regulation and client expectations demand safer sanitation.
The HexyTrix platform reduces bacteria, viruses and fungi through a physicochemical mode of action, limiting aggressive chemicals and the risk of residues. It does not sediment, leaves no toxic residue and does not affect food properties, providing both immediate disinfection and long-lasting reduction of pathogen regrowth.
Disinfection effectiveness goes hand in hand with human safety, infrastructure durability and compliance, supporting consumer safety, employee protection and brand reputation.
Graphene is transforming modern medicine through advanced antibacterial protection, innovative wound care, precise drug delivery and next-generation medical technologies. Its single-layer hexagonal carbon lattice delivers extraordinary strength, conductivity and antibacterial properties.
Graphene layers eliminate bacteria by disrupting cell membranes and generating reactive oxygen species. They protect wounds from infection, accelerate tissue regeneration and reduce complications, ideal for post-surgical wounds, burns and chronic ulcers.
Protect wounds from infection, accelerate regeneration and reduce complications for post-surgical wounds, burns and chronic ulcers.
Air and water filters with graphene nanolayers eliminate pathogens, fungi and viruses in hospitals, labs and portable field sterilization.
Graphene fibers in brush bristles and coated heads provide antibacterial effects, reduce plaque and support gum protection.
Protective layers on surgical tools, implants and prosthetics minimize the risk of postoperative infection.
A vast surface area and biocompatibility let graphene carry therapeutic agents directly to target cells, valuable in oncology and chronic disease.
Graphene is already transforming the standards of treatment, sterilization and healthcare protection. We combine science, engineering and practical application to unlock its potential.
Graphene is redefining dentistry, enhancing implant safety, strengthening fillings, improving oral hygiene and delivering advanced antibacterial protection for healthier, longer-lasting dental care.
Dentistry has long faced infections around implants, tooth decay and the durability of fillings. Traditional materials work, but rarely provide lasting antibacterial protection or full biocompatibility.
Graphene's antibacterial properties and mechanical strength improve treatment effectiveness, extend implant durability and support oral hygiene, redefining prevention with more comfort and safety.
Reduce the risk of infection and accelerate integration of implants with bone tissue.
Graphene additives strengthen the structure, making fillings more resistant to wear.
Graphene fibers and surfaces act as antibacterial agents, reducing plaque and cavity risk.
Graphene nanoparticles in rinses or toothpaste enhance antibacterial effects.
Graphene is setting new standards in veterinary medicine, improving animal hygiene, preventing infection, supporting faster healing and creating safer, more sustainable health solutions for modern farming.
In dairy farming, udder health is essential for milk quality and safety, and fungal and bacterial mastitis causes losses and reduces welfare.
Graphene coatings on milking components, teat cups, hoses and skin-contact parts, form a strongly antibacterial and antifungal layer that disrupts pathogen membranes and inhibits reproduction, cutting infection risk without heavy reliance on chemical disinfectants.
Graphene-based wound dressings accelerate healing in farm and companion animals while protecting from infection.
Nanolayers reduce bacteria and fungi where animals eat and drink.
Graphene filters provide clean drinking water, eliminating pathogens and improving herd health.
Graphene-coated instruments lower infection risk during procedures.
A step toward farming where hygiene and animal welfare go hand in hand with production efficiency.
Graphene is shaping the future of healthcare through intelligent diagnostics, advanced protective technologies, tissue regeneration and next-generation medical innovation that redefines modern science.
Its 2D structure, enormous surface area and excellent conductivity let graphene work across disciplines, from fast diagnostics to tissue engineering. It bridges biology, chemistry and advanced materials, laying the foundation for next-generation medicine.
Real-time diagnostics detecting viruses, bacteria and disease biomarkers.
Gowns, suits and gloves with graphene coatings that eliminate pathogens in hospitals and labs.
Precise delivery of active substances to targeted cells.
Graphene scaffolds supporting regeneration of muscle and nerve tissue.
Orthopedic and surgical implants with higher biocompatibility and reduced rejection risk.
Hospital and laboratory clothing is the first line of protection for medical staff against biological hazards. Despite strict laundering, secondary contamination remains one of the most serious and least visible risks in healthcare.
Right after washing, garments rapidly re-accumulate bacteria during storage, transport, dressing and first contact with the environment. Textiles provide an ideal surface for recolonization, so conventional laundering offers only short-term protection.
In diagnostic labs and operating rooms, even minimal pathogen presence on clothing raises the risk of cross-contamination and occupational exposure.
We impregnate textiles with a natural graphene oxide preparation. Treated clothing gains long-lasting antibacterial, antiviral and antifungal properties that persist far beyond conventional disinfection, actively suppressing microbial presence through extended use.
Reduced reliance on aggressive laundering also lowers detergent use, extends textile lifespan and cuts operating costs while minimizing environmental impact.
A higher level of biological safety that reduces occupational risk for doctors and lab staff, extends textile durability and represents a responsible, forward-looking approach to healthcare protection.
Medical and industrial laundry services maintain sanitary safety across hospitals, labs, industry and hospitality. Yet standard laundering provides only temporary cleanliness, textiles begin re-accumulating pathogens the moment a cycle ends.
Even with high temperatures and strong detergents, textiles re-contaminate during drying, transport, storage and initial use, so conventional processes eliminate risk only momentarily.
In medical laundry, uniforms, bedding and surgical textiles can become vectors for cross-contamination. In industrial laundry, intensive chemical use accelerates fabric degradation and raises costs.
We impregnate textiles with a natural graphene oxide preparation as a complement to standard laundering. Fabrics gain long-lasting antibacterial, antiviral and antifungal properties across repeated cycles, shifting from reactive disinfection to active, long-term protection.
Biological effectiveness, human safety, textile durability and environmental responsibility, for institutions seeking to elevate hygiene standards without increasing cost or risk.
Public transport and logistics are among the most sanitary-sensitive segments of modern infrastructure. High passenger turnover, enclosed spaces, air-conditioning and shared surfaces create ideal conditions for bacteria, viruses and fungi.
High-concentration alcohols, aldehydes, chlorine compounds and oxidizers offer short-term effect, but long-term use accelerates material degradation, corrodes metal, damages plastics and upholstery and shortens vehicle lifespan.
Harsh disinfectants also harm human health, and residues and vapors can persist in enclosed transport environments long after application.
The HexyTrix graphene oxide platform is designed for user safety and material compatibility. Applied as a stable aqueous dispersion, it does not sediment, evaporate uncontrollably or leave toxic residue, providing immediate disinfection plus a long-lasting protective effect.
Sanitary safety that goes hand in hand with human health protection and long-term infrastructure durability, safe for humans, animals and the environment.
Food processing and transport are among the most demanding sectors for hygiene. Products move through lines, cold storage, warehouses and vehicles, where even minimal contamination can create serious health risks and losses.
Bacteria, viruses and fungi threaten production surfaces, packaging lines, transport containers and cold-chain environments. The challenge is disinfecting food-contact areas while maintaining product quality, freshness and safety.
Chlorine agents, peroxides, aldehydes and ammonium compounds act fast but risk residues migrating into food, accelerate equipment wear and raise maintenance costs, against tightening regulation and consumer expectations.
The HexyTrix platform reduces bacteria, viruses and fungi while minimizing aggressive chemicals and residues. Delivered as a stable aqueous dispersion, it does not sediment or alter food properties, providing immediate action and long-lasting microbiological protection.
A standard in which quality, safety and responsibility go hand in hand, extending infrastructure lifespan and minimizing environmental impact.
HoReCa is one of the most demanding sectors for hygiene and responsibility toward guests. Hotels, restaurants and kitchens serve thousands daily, with intensive contact with food, shared surfaces, textiles and high turnover.
Strong detergents, chlorine agents, alcohols and biocides give immediate visual results, but long-term use irritates skin and airways, wears surfaces and leaves residues, an increasingly negative factor for health-conscious guests.
Conventional disinfection also works only temporarily, and high-traffic areas are recolonized shortly after cleaning, forcing costly, repeated processes.
Natural graphene oxide preparations eliminate bacteria, viruses and fungi without aggressive chemicals, providing a long-lasting protective effect. Delivered as stable aqueous dispersions, they limit recolonization without toxic residue or any impact on guest comfort.
Beyond the smell of chemicals and surface shine, real, long-lasting biological safety, for venues combining hygiene, sustainability and advanced technology.
INTERMERCATUS Tech operates in sectors already shaping the global economy: biotechnology, graphene nanotechnology, digital health, CLEANTECH and advanced solutions for industry, medicine and agriculture, markets with exceptional long-term growth potential.
Our strategy builds an ecosystem where business areas reinforce one another. We develop both core material technologies, graphene and nanomaterials, and applied solutions across disinfection, CLEANTECH, Life Sciences, HealthTech and AI for medicine, diversifying revenue and scaling across markets at once.
This structure reduces operational risk while increasing resilience to economic cycles.
Our solutions address real global challenges rather than short-term trends: aging populations, overloaded healthcare systems, demand for safe and sustainable disinfection, environmental pressure and the need to support medical professionals, challenges that will define markets for decades.
For investors this means a company with a long-term vision and clearly defined growth pathways, strong licensing potential, B2B and OEM models and the ability to expand globally, with value built through proprietary technologies, deep know-how, a strong team and an international structure.
An opportunity for investors seeking not only financial returns but participation in the development of technologies that create real, lasting change.
INTERMERCATUS Tech offers two complementary investment models, designed for different strategies, levels of involvement and expectations around risk and return.
Purchasing shares in INTERMERCATUS Tech Inc., the owner and integrator of the entire group, makes you a co-owner of the whole group with exposure to multiple sectors at once, Life Sciences, CLEANTECH, graphene technologies and medical IT.
You hold strategically liquid shares within a U.S. corporate structure preferred by international investors, ideal for broad exposure to group-wide growth.
A dedicated investment agreement targets a specific project or subsidiary, letting you allocate capital to a chosen technology, gain direct influence over its development, hold equity in the responsible entity and manage risk and return with greater precision.
This suits investors who want to actively shape a chosen technology from R&D through commercialization.
Both broad exposure to the growth of an integrated technology group and targeted opportunities in future-defining innovations.